期刊论文详细信息
Cancers
Fertility-Sparing Treatment for Endometrial Cancer: Oncological and Obstetric Outcomes in Combined Therapies with Levonorgestrel Intrauterine Device
Davide Radice1  Ida Pino2  Anna Daniela Iacobone2  Ailyn Mariela Vidal Urbinati2  Eleonora Petra Preti2  Maria Elena Guerrieri2  Silvia Martella2  Dorella Franchi2  Maria Di Giminiani3 
[1] Division of Epidemiology and Biostatistics, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy;Preventive Gynecology Unit, European Institute of Oncology IRCCS, 20141 Milan, Italy;Unit of Obstetrics and Gynecology, ASST Fatebenefratelli-Sacco, Department of Biological and Clinical Sciences L. Sacco, University of Milan, 20157 Milan, Italy;
关键词: endometrial cancer;    fertility-sparing treatment;    obstetric outcomes;    oncological outcomes;   
DOI  :  10.3390/cancers14092170
来源: DOAJ
【 摘 要 】

Background: The prevalence of reaches up to 5% in women younger than 40 years. Therefore, the fertility preservation should be the goal of the clinical practice in women with desire of pregnancy and low-risk features. The aim of this study is to compare oncological and reproductive outcomes of different hormonal therapies in FST of EC. Methods: A retrospective single-center study recruiting patients with presumed FIGO STAGE IA endometrioid G1 EC from 2005 to 2020 was performed. We assessed outcomes for three different therapeutic options: GnRHa + LNG-IUD vs. MA + LNG-IUD vs. MA + LNG-IUD + MET. Results: In total, 75 patients were enrolled and followed up for a median of 45 months. Complete response (CR) was achieved in 75% of patients at 12 months. Although not statistically significant, we reported an increasing rate of CR from the regimen with GnRHa to the one with MA + MET (65% vs. 83%). We showed a statistically significant lower risk of recurrence in women treated with MA + LNG-IUD + MET, when compared to GnRHa + LNG-IUD regimen. The pregnancy rate was 74% and live birth rate was 42%, with no differences among regimens. Conclusions: FST is a safe and effective option in women who desire to preserve fertility.

【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:1次